NVMI · Nova Ltd. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $880.58M | $672.40M | $517.92M | $570.73M | $416.11M | $269.40M |
| Cost of Revenue | $375.38M | $285.31M | $224.75M | $253.76M | $178.75M | $116.47M |
| Gross Profit | $505.20M | $387.09M | $293.18M | $316.97M | $237.36M | $152.92M |
| R&D | $143.39M | $110.26M | $88.04M | $90.46M | $65.86M | $53.02M |
| SG&A | $26.13M | $24.20M | $20.40M | $23.85M | $17.32M | $12.51M |
| Total Operating Expenses | $251.73M | $199.55M | $160.91M | $167.04M | $124.97M | $97.35M |
| D&A | $13.47M | $11.74M | $10.34M | $8.62M | $6.47M | $5.88M |
| Operating Income | $253.47M | $187.54M | $132.26M | $149.93M | $112.39M | $55.57M |
| Interest Expense | $2.00M | $1.28M | $1.28M | $1.28M | $0 | $868.0K |
| Income Tax | $44.06M | $32.52M | $18.39M | $18.20M | $16.15M | $8.59M |
| Net Income | $259.22M | $183.76M | $136.31M | $140.21M | $93.10M | $47.91M |
| EPS - Basic | $8.61 | $6.31 | $4.73 | $4.89 | $3.28 | $1.71 |
| EPS - Diluted | $7.96 | $5.75 | $4.28 | $4.40 | $3.12 | $1.65 |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $214.46M | $157.78M | $107.57M | $111.12M | $126.70M | $232.30M |
| Accounts Receivable | $151.93M | $139.32M | $111.26M | $109.32M | $68.45M | $63.31M |
| Inventory | $183.67M | $156.60M | $138.20M | $116.60M | $78.67M | $61.73M |
| Accounts Payable | $46.98M | $59.58M | $35.16M | $42.73M | $36.22M | $24.10M |
| Current Assets | $1.41B | $901.95M | $710.22M | $612.95M | $566.52M | $558.70M |
| Total Assets | $2.36B | $1.39B | $1.13B | $984.11M | $805.15M | $655.79M |
| Current Liabilities | $224.53M | $388.23M | $322.81M | $134.07M | $287.93M | $60.93M |
| Long-term Debt | - | - | - | - | - | - |
| Total Liabilities | $1.04B | $462.63M | $383.06M | $397.14M | $331.40M | $284.25M |
| Stockholders' Equity | $1.32B | $927.79M | $750.75M | $586.96M | $473.75M | $371.54M |
| Retained Earnings | $1.06B | $798.14M | $614.38M | $478.07M | $334.72M | $241.62M |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | $245.61M | $235.27M | $123.53M | $119.54M | $132.26M | $60.25M |
| Investing Cash Flow | ($837.17M) | ($136.40M) | ($125.33M) | ($100.26M) | ($238.50M) | ($42.46M) |
| Financing Cash Flow | $642.21M | ($48.35M) | $10.0K | ($29.81M) | $11.0K | $181.41M |
| CapEx | $27.70M | $17.21M | $17.19M | $21.31M | $4.82M | $6.44M |
| Free Cash Flow | $217.91M | $218.05M | $106.34M | $98.22M | $127.45M | $53.81M |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | 57.4% | 57.6% | 56.6% | 55.5% | 57.0% | 56.8% |
| Operating margin | 28.8% | 27.9% | 25.5% | 26.3% | 27.0% | 20.6% |
| EBITDA margin | 30.3% | 29.6% | 27.5% | 27.8% | 28.6% | 22.8% |
| Net margin | 29.4% | 27.3% | 26.3% | 24.6% | 22.4% | 17.8% |
| Free cash flow margin | 24.7% | 32.4% | 20.5% | 17.2% | 30.6% | 20.0% |
| FCF / Net income | 0.84 | 1.19 | 0.78 | 0.70 | 1.37 | 1.12 |
| R&D / Revenue | 16.3% | 16.4% | 17.0% | 15.8% | 15.8% | 19.7% |
| SG&A / Revenue | 3.0% | 3.6% | 3.9% | 4.2% | 4.2% | 4.6% |
| Effective tax rate | 14.5% | 15.0% | 11.9% | 11.5% | 14.8% | 15.2% |
| Return on assets | 11.0% | 13.2% | 12.0% | 14.2% | 11.6% | 7.3% |
| Return on equity | 19.7% | 19.8% | 18.2% | 23.9% | 19.7% | 12.9% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 6.28 | 2.32 | 2.20 | 4.57 | 1.97 | 9.17 |
| Quick ratio | 5.47 | 1.92 | 1.77 | 3.70 | 1.69 | 8.16 |
| Cash ratio | 0.96 | 0.41 | 0.33 | 0.83 | 0.44 | 3.81 |
| Leverage | ||||||
| Debt / Equity | - | - | - | - | - | - |
| Debt / Assets | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | 127.0x | 146.5x | 103.0x | 117.0x | - | 64.0x |
| Equity multiplier | 1.79 | 1.50 | 1.51 | 1.68 | 1.70 | 1.77 |
| Liabilities / Assets | 0.44 | 0.33 | 0.34 | 0.40 | 0.41 | 0.43 |
| Efficiency | ||||||
| Asset turnover | 0.37 | 0.48 | 0.46 | 0.58 | 0.52 | 0.41 |
| Inventory turnover | 2.04 | 1.82 | 1.63 | 2.18 | 2.27 | 1.89 |
| Days sales outstanding | 63d | 76d | 78d | 70d | 60d | 86d |
| Days inventory outstanding | 179d | 200d | 224d | 168d | 161d | 193d |
| Days payable outstanding | 46d | 76d | 57d | 61d | 74d | 76d |
| Cash conversion cycle | 196d | 200d | 246d | 176d | 147d | 204d |
| Valuation | ||||||
| P / E | 41.3x | 34.3x | 32.1x | 18.6x | 47.0x | 42.8x |
| P / B | 0.0x | 0.0x | 0.0x | 4.4x | 9.2x | 5.5x |
| P / S | 0.0x | 0.0x | 0.0x | 4.6x | 10.5x | 7.6x |
| EV / EBITDA | -0.8x | -0.8x | -0.7x | 15.7x | 35.7x | 29.5x |
| Growth | ||||||
| Revenue growth (YoY) | 31.0% | 29.8% | -9.3% | 37.2% | 54.5% | 19.8% |
| Revenue CAGR (3y) | 15.6% | 17.3% | 24.3% | 36.4% | 18.3% | 6.7% |
| Revenue CAGR (5y) | 26.7% | 24.5% | 15.6% | 20.8% | 20.5% | 12.6% |
| Gross profit growth (YoY) | 30.5% | 32.0% | -7.5% | 33.5% | 55.2% | 25.5% |
| Operating income growth (YoY) | 35.2% | 41.8% | -11.8% | 33.4% | 102.2% | 52.6% |
| Net income growth (YoY) | 41.1% | 34.8% | -2.8% | 50.6% | 94.3% | 36.2% |
| EPS growth (YoY) | 38.4% | 34.3% | -2.7% | 41.0% | 89.1% | 34.1% |
| EPS CAGR (3y) | 21.8% | 22.6% | 37.4% | 52.9% | 18.2% | 0.4% |
| EPS CAGR (5y) | 37.0% | 36.1% | 17.8% | 22.0% | 54.9% | 23.7% |
| FCF growth (YoY) | -0.1% | 105.0% | 8.3% | -22.9% | 136.8% | 170.0% |
| FCF CAGR (5y) | 32.3% | 61.4% | 26.8% | - | - | 20.2% |
| Book value growth (YoY) | 42.1% | 23.6% | 27.9% | 23.9% | 27.5% | 18.1% |
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
1.98
Grey zone
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
3/9
Weak
- ✓Net income positive
- ✓Operating cash flow positive
- ✗ROA improved YoY
- ✗Cash flow > net income
- -Long-term debt decreased
- ✓Current ratio improved
- ✗No share dilution
- ✗Gross margin improved
- ✗Asset turnover improved
Peer comparison
Same SIC group: Optical Instruments & Lenses
Comparing NOVA LTD. against the 5 most active filers in the same SIC group.